Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4061915
Max Phase: Preclinical
Molecular Formula: C26H37ClN3NaO8S
Molecular Weight: 588.12
Molecule Type: Small molecule
Associated Items:
ID: ALA4061915
Max Phase: Preclinical
Molecular Formula: C26H37ClN3NaO8S
Molecular Weight: 588.12
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C1CC[C@@H](C(O)S(=O)(=O)[O-])NC(=O)C2(CCCCC2)NC(=O)OC(c2cccc(Cl)c2)CCCCCCN1.[Na+]
Standard InChI: InChI=1S/C26H38ClN3O8S.Na/c27-19-10-8-9-18(17-19)21-11-4-1-2-7-16-28-22(31)13-12-20(23(32)39(35,36)37)29-24(33)26(30-25(34)38-21)14-5-3-6-15-26;/h8-10,17,20-21,23,32H,1-7,11-16H2,(H,28,31)(H,29,33)(H,30,34)(H,35,36,37);/q;+1/p-1/t20-,21?,23?;/m0./s1
Standard InChI Key: VHYRPKWOABGPDW-TUKXYOOQSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 588.12 | Molecular Weight (Monoisotopic): 587.2068 | AlogP: 3.36 | #Rotatable Bonds: 3 |
Polar Surface Area: 171.13 | Molecular Species: ACID | HBA: 7 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: -0.80 | CX Basic pKa: | CX LogP: 1.98 | CX LogD: 0.70 |
Aromatic Rings: 1 | Heavy Atoms: 39 | QED Weighted: 0.33 | Np Likeness Score: 0.19 |
1. Damalanka VC, Kim Y, Galasiti Kankanamalage AC, Lushington GH, Mehzabeen N, Battaile KP, Lovell S, Chang KO, Groutas WC.. (2017) Design, synthesis, and evaluation of a novel series of macrocyclic inhibitors of norovirus 3CL protease., 127 [PMID:28038326] [10.1016/j.ejmech.2016.12.033] |
Source(1):